Blog
RSS FeedPosted by Michael Wonder on 15 Mar 2022
New access tool launched as part of SMC’s joint work on streamlining patient access to innovative medicines
8 March 2022 - A new UK wide health technology assessment access forum has been developed by partners including the ...
Posted by Michael Wonder on 24 Jan 2022
Breast cancer patients in Scotland are set to receive tumour blasting wonder drug that starts working in weeks - sparking hopes of a wider rollout for NHS patients across the rest of the UK
23 January 2022 - A breast cancer drug that can melt away tumours in weeks has been given the green ...
Posted by Michael Wonder on 13 Oct 2021
Scotland is first country to offer free digital therapies to every adult
13 October 2021 - The Scottish Government has announced that all Scottish adults will now have access to "digital therapeutics" ...
Posted by Michael Wonder on 13 Apr 2021
Scotland opens door to Translarna for Duchenne muscular dystrophy
13 April 2021 - A disparity in UK access to a medicine for Duchenne muscular dystrophy has been addressed, after ...
Posted by Michael Wonder on 08 Mar 2021
World's most expensive drug given the green light in Scotland
8 March 2021 - A medicine known as the most expensive in the world has been approved to treat a rare ...
Posted by Michael Wonder on 11 Jan 2021
SMC to support innovative new medicines pathway
29 December 2020 - Experts from the Scottish Medicines Consortium are to support a new licensing and access pathway which ...
Posted by Michael Wonder on 12 Nov 2020
After NICE okay, Scots denied access to Vifor’s Veltassa
10 November 2020 - The SMC has ruled that there’s not enough evidence to support NHS funding of Vifor Pharma’s ...
Posted by Michael Wonder on 23 Sep 2020
SMC plays key role in helping to secure access to COVID-19 treatments
15 September 2020 - The Scottish Medicines Consortium is part of a UK-wide multi-agency initiative to secure access to potential ...
Posted by Michael Wonder on 08 Sep 2020
SMC accepts three new health technologies for interim use
7 September 2020 - In what appears to be a new process, the SMC has accepted three new technologies for ...
Posted by Michael Wonder on 08 Sep 2020
ICR welcomes approval of immunotherapy for head and neck cancer in Scotland but warns of ‘home nations lottery’
7 September 2020 - The Institute of Cancer Research, London, has welcomed the approval by the Scottish Medicines Consortium of ...
Posted by Michael Wonder on 07 Sep 2020
Four new medicines accepted by SMC through an expedited approach
7 September 2020 - Medicines accepted to minimise delay in patient access following the early phase of the COVID-19 pandemic. ...
Posted by Michael Wonder on 09 Aug 2020
'Tears of joy' as new drug ready for cystic fibrosis patient
8 August 2020 - A woman waiting for the approval of a delayed drug that could save her life says ...
Posted by Michael Wonder on 22 Jan 2020
Supporting innovative medicines funding in Scotland
21 January 2020 - Scotland receives superb value from the latest medicines and vaccines thanks to robust measures which ensure ...
Posted by Michael Wonder on 13 Sep 2019
Vertex announces new access agreement with Scottish Government for Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor)
12 September 2019 - Eligible patients in Scotland will immediately have access to Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor) in combination with ...
Posted by Michael Wonder on 15 Jul 2019
Brexit: 'No guarantee' of medicines if no EU deal agreed
14 July 2019 - Scottish Brexit Secretary Mike Russell has said he cannot absolutely guarantee the supply of medicine to ...